Cutler Group LP Intellia Therapeutics, Inc. Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$23.16 - $32.34 $16,212 - $22,638	-700 Reduced 77.78%	200 $6,000
Q3 2023 Nov 07, 2023	BUY	$31.62 - $45.78 $15,810 - $22,890	500 Added 125.0%	900 $28,000
Q1 2023 May 01, 2023	SELL	$33.3 - $44.82 $3,329 - $4,482	-100 Reduced 20.0%	400 $14,000
Q4 2022 Feb 07, 2023	SELL	$33.21 - $62.69 $199,260 - $376,140	-6,000 Reduced 92.31%	500 $17,000
Q3 2022 Oct 25, 2022	BUY	$53.92 - $71.7 $80,880 - $107,550	1,500 Added 30.0%	6,500 $363,000
Q2 2022 Aug 04, 2022	BUY	$38.49 - $76.21 $11,777 - $23,320	306 Added 6.52%	5,000 $258,000
Q1 2022 Apr 14, 2022	BUY	$58.27 - $118.99 $261,865 - $534,741	4,494 Added 2247.0%	4,694 $341,000
Q4 2021 Jan 18, 2022	SELL	$100.76 - $138.36 $14,106 - $19,370	-140 Reduced 41.18%	200 $23,000
Q3 2021 Oct 26, 2021	SELL	$132.37 - $176.78 $1.17 Million - $1.57 Million	-8,860 Reduced 96.3%	340 $45,000
Q2 2021 Jul 19, 2021	BUY	$60.88 - $161.91 $560,096 - $1.49 Million	9,200 New	9,200 $1.49 Million
Q3 2018 Nov 07, 2018	SELL	$25.78 - $32.6 $35,112 - $44,401	-1,362 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$20.02 - $30.79 $54,054 - $83,133	-2,700 Reduced 66.47%	1,362 $37,000
Q1 2018 May 11, 2018	BUY	$19.43 - $34.95 $55,647 - $100,096	2,864 Added 239.07%	4,062 $85,000
Q4 2017 Jan 17, 2018	SELL	$17.39 - $31.12 $57,004 - $102,011	-3,278 Reduced 73.24%	1,198 $23,000
Q3 2017 Oct 17, 2017	BUY	$15.16 - $25.75 $67,856 - $115,257	4,476	4,476 $111,000

316

91.7M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.